Феърфилд
[ ]
Клевудин (Clevudine)
Международное непатентованное наименование Клевудин (Clevudine)
Торговое наименование Levovir, Revovir
Производитель, страна Bukwang Pharmaceutical, The Republic of Korea
Лекарственная форма tablet, 100 mg
Механизм действия

Clevudine is an antiviral nucleoside analog drug. Upon entry into the cell, it is phosphorylated to its active state where it is incorporated into viral DNA in competition with the common nucleotide thymidine. Incorporation by viral polymerase leads to early DNA chain termination and thus non-viable viral progeny.

Клинические исследования
1.
Название протокола The Randomized, Open, Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19
Дата начала и окончания КИ April 24, 2020 - December 31, 2020
Название организации, проводящей КИ Bukwang Pharmaceutical
Страны Republic of Korea
Фаза II
Кол-во пациентов 60